Artificial intelligence for post-treatment prediction in age-related macular degeneration
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Ophthalmology pioneered the clinical use of artificial intelligence (AI). Beyond automating routine tasks, including retinal disease screening via fundus photography and optical coherence tomography (OCT),1,2 AI now excels at complex challenges such as sex differentiation based on OCT images,3 which often eludes even human experts. Building on earlier breakthroughs in ophthalmology, Xinyu Zhao and colleagues4 advanced the use of AI in the field. Their KongMing Model, published in The Lancet Digital Health, uses a novel structural attention-guided therapeutic response predicting model that successfully predicted both anatomical and functional changes in patients with neovascular age-related macular degeneration (nAMD) treated with conbercept (an anti-vascular endothelial growth factor [anti-VEGF]).
Fields of Study & Subjects
Retinal Imaging and Analysis
Retinal Diseases and Treatments
Artificial Intelligence in Healthcare and Education
Publication details
- Journal / source
- The Lancet Digital Health
- Volume
- 8
- Issue
- 4
- Pages
- 100997–100997
- Publication date
- 26 March 2026
- Language
- EN